BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24337364)

  • 1. Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus.
    Caletti MG; Balestracci A; Di Pinto D
    Pediatr Nephrol; 2014 Mar; 29(3):487-90. PubMed ID: 24337364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poiseuille's law in polyuria.
    Schreuder MF; Koster-Kamphuis L
    Pediatr Nephrol; 2014 Jul; 29(7):1289. PubMed ID: 24781269
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V; Koller DY; Seidl R; Waldhauser F
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
    Hochberg Z; Even L; Danon A
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):39-44. PubMed ID: 9797845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrogenic diabetes insipidus in a large family].
    Kaltenis P; Jankauskiene A
    Medicina (Kaunas); 2006; 42(2):137-41. PubMed ID: 16528130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessive type of nephrogenic diabetes insipidus.
    Vandermarliere A; Maes B; Vanrenterghem Y
    Am J Kidney Dis; 2003 Oct; 42(4):A41, E1. PubMed ID: 14520647
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient.
    Konoshita T; Kuroda M; Kawane T; Koni I; Miyamori I; Tofuku Y; Mabuchi H; Takeda R
    Horm Res; 2004; 61(2):63-7. PubMed ID: 14646392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
    Soylu A; Kasap B; Oğün N; Oztürk Y; Türkmen M; Hoefsloot L; Kavukçu S
    Pediatr Nephrol; 2005 Dec; 20(12):1814-7. PubMed ID: 16240160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic Diabetes Insipidus.
    Kavanagh C; Uy NS
    Pediatr Clin North Am; 2019 Feb; 66(1):227-234. PubMed ID: 30454745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R; Brodehl J
    Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N; Monnens LA
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to low dose indomethacin in two children with nephrogenic diabetes insipidus.
    Dayal D; Verma Attri S; Kumar Bhalla A; Kumar R
    Pediatr Endocrinol Diabetes Metab; 2015; 20(4):178-81. PubMed ID: 26615585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment regimens by pediatric nephrologists in children with congenital nephrogenic diabetes insipidus: A MWPNC study
.
    D'Alessandri-Silva C; Carpenter M; Mahan JD
    Clin Nephrol; 2018 May; 89(5):358-363. PubMed ID: 29162216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital Nephrogenic Diabetes Insipidus Presented With Bilateral Hydronephrosis and Urinary Infection: A Case Report.
    Zheng K; Xie Y; Li H
    Medicine (Baltimore); 2016 May; 95(22):e3464. PubMed ID: 27258490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
    Lam SS; Kjellstrand C
    Ren Fail; 1997 Jan; 19(1):183-8. PubMed ID: 9044466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrogenic diabetes insipidus associated with lithium therapy.
    Nandoshvili E; Hyer S; Johri N
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31494590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic renal complications induced by lithium].
    Le Roy V; Delmas Y; Verdoux H
    Encephale; 2009 Dec; 35(6):605-10. PubMed ID: 20004292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.